Original Research
Accepted on 22 Aug 2025
CCDC58 drives lung adenocarcinoma progression via the PI3K/AKT signaling pathway
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1619123
- 100 views
Type at least 3 characters
1,467 articles
Original Research
Published on 22 Aug 2025
A high stroma-tumor ratio is associated with an immunosuppressive tumor microenvironment and a poor prognosis in bladder cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1604609
- 410 views
Original Research
Accepted on 21 Aug 2025
Analyzing the impact of Human Leukocyte Antigen (HLA) mismatch on the incidence of prostate cancer and the advantage of T cell therapy in patients after kidney transplantation based on the United Network for Organ Sharing (UNOS) database
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1562869
- 110 views
Original Research
Accepted on 21 Aug 2025
Phenotypes of synovial fluid Treg cells in checkpoint blockade-related inflammatory arthritis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1628790
- 128 views
Review
Accepted on 20 Aug 2025
(Word count:8503) Challenges and Breakthroughs: Current Landscape and Future Prospects of CAR-T Cell Therapy Clinical Trials for Solid Tumors
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1652329
- 138 views
Case Report
Accepted on 20 Aug 2025
Successful rescue of PD-1 inhibitor-induced TEN by vincristine combination therapy: a case report and literature review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1621494
Correction
Accepted on 20 Aug 2025
Correction: TPL inhibits the invasion and migration of drug-resistant ovarian cancer by targeting the PI3K/AKT/NF-κB-signaling pathway to inhibit the polarization of M2 TAMs
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1641399
- 115 views
Original Research
Accepted on 20 Aug 2025
Application of Immunotherapy in Advanced Non-small Cell Lung Cancers With Hypertension: a Multicenter Retrospective Analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1621363
- 101 views
Correction
Accepted on 19 Aug 2025
Correction: Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1654169
- 134 views
Brief Research Report
Published on 19 Aug 2025
Effectiveness and safety of nivolumab and ipilimumab in older adults with renal cell carcinoma: findings from a multicenter observational study in Poland
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1617743
- 469 views
Original Research
Published on 18 Aug 2025
Retrospective analysis of clinical characteristics and treatment of patients with immune checkpoint inhibitors-induced adrenal insufficiency
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1614223
- 553 views
Review
Published on 18 Aug 2025
A review of the participation of DDIT4 in the tumor immune microenvironment through inhibiting PI3K-Akt/mTOR pathway
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1595463
- 415 views
Review
Published on 15 Aug 2025
CD70 as a target in cancer immunotherapy: advances, challenges, and future directions
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1609840
- 488 views
Original Research
Published on 15 Aug 2025
PNI as a predictive biomarker: a novel nomogram of immunotherapy efficacy in advanced breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1534545
- 486 views
Case Report
Published on 15 Aug 2025
Safety and clinical efficacy of immune checkpoint inhibitors in pediatric hepatocellular carcinoma: a case report and review of the literature
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1576892
- 421 views
Original Research
Accepted on 13 Aug 2025
The Application of Peripheral Blood Immune Profiling in Personalized Treatment of Locally Advanced and Advanced Lung Cancer: A Nomogram Approach
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1642829
- 100 views